Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_assertion type Assertion NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_head.
- NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_assertion description "[Here, we demonstrate that erlotinib-induced cell growth inhibition in EGFR high-expressing human H322 NSCLC cells was accompanied by G1/S phase arrest, which was largely caused by a decrease in expression of G1/S-related cyclins, suppression of activities of cyclin-dependent kinase (CDK) 2 and CDK4, induction of CDK inhibitor p27(KIP1), and retinoblastoma hypophosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_provenance.
- NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_assertion evidence source_evidence_literature NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_provenance.
- NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_assertion SIO_000772 17456787 NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_provenance.
- NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_assertion wasDerivedFrom befree-20140225 NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_provenance.
- NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_assertion wasGeneratedBy ECO_0000203 NP937093.RAQO44EV9y5bdHYe2wZaf24cm-ZA-r7pSRCJm0I_2iFE0130_provenance.